UPMC logo UPCI logo NCI logo
About Us | News | Jobs | Giving | Volunteer | Contact Us
Search

Prostate Cancer

Partin Coefficient Table III: PSA = 10.1 – 20.0 ng/ml

This table shows the probability of having each of the four pathologic stages of prostate cancer based on Gleason score, clinical stage and a PSA level between 10.1 and 20.0 ng/ml.


Examples

  • A man with a PSA level of 13.3 ng/ml, a Gleason score of 3 and a clinical stage of T1c has a 75% chance of having organ-confined disease.

  • A man with a PSA level of 18.7 ng/ml, a Gleason score of 6 and a clinical stage of T2c has a 9% chance of seminal vesicle involvement.


PSA = 10.1 – 20.0 ng/ml
Probability of Pathologic Stage (%)
   
Clinical Stage
Gleason score
Pathologic stage

T1a

T1b

T1c

T2a

T2b

T2c

T3a

2-4
Organ-confined disease

Established capsular penetration

Seminal
vesicle involvement

Lymph node involvement



76



20



2


0



58



36



4


2



75



22



2


0



60



35



4


1



48



43



7


1



53



37



8


1















5
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement



61



33



3


3



40



50



5


5



60



35



3


1



43



50



5


2



32



57



8


4



36



51



9


4



18



59



15


7

6
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement

















33



49



4


13



55



38



4


3



38



52



5


4



26



57



7


10



31



50



9


10



14



54



14


18

7
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement



33



38



8


18



17



46



11


24



35



45



12


8



22



55



14


9



13



51



18


17



15



45



22


18



6



40



28


26

8-10
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement

















9



33



15


40



23



40



20


16



14



46



22


17



7



38



25


29



8



33



30


29



3



26



34


37

… lack of sufficient data to calculate probability

Reference: Partin AW, Kattan MW, Subong EN, Walsh PC, et al. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. JAMA 1997;277:1445-1451. Copyrighted 1997, American Medical Association. Reprinted with permission.



About This Web Site | Give Us Your Feedback | Privacy Statement | Disclaimer | Informatics Web Resources

© UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
412-647-2811 | PCI-INFO@upmc.edu |
Send questions and comments to UPCIwebupdates@upmc.edu